GHAPPcast: Biosimilars Unveiled: Empowering APPs for Better Patient Conversations

Thank you to Boehringer Ingelheim for your support of this podcast.In this episode of GHAPPcast, the official podcast for Gastroenterology and Hepatology Advanced Practice Providers, host Gabriella McCarty, NP, is joined by Tedra Gray, NP, to explore the role of biosimilars in GI treatment. They dive into the differences between biosimilars and generics, the cost savings associated with biosimilars, their safety and efficacy, and strategies for effectively educating patients about making the switch. With insights into the FDA approval process, insurance challenges, and real-world clinical experience, this discussion provides essential guidance for APPs looking to enhance patient care and communication.Key topics covered include what biosimilars are and how they differ from generics, the benefits of switching to a biosimilar—including improved access and cost savings—how biosimilars are tested for safety and efficacy, and best practices for discussing these treatments with patients. The episode also addresses common patient concerns, potential barriers to biosimilar adoption, and how to navigate insurance requirements.To stay informed, visit ghapp.org for more resources or download the GHAPP ACE app. Don’t forget to subscribe to GHAPPcast for more expert insights into gastroenterology and hepatology. Tune in now to gain valuable knowledge that will help you empower your patients and improve their treatment experience.